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Introduction
The term spondylometaphyseal dysplasia Algerian type
(SMD-A; MIM no.: 184253) was introduced by Kozlowski
et al1 who reported five cases in an Algerian family. Subse-
quently, Rybak et al2 reported a sporadic case in a Polish boy
and considered SMD-A as a distinctive skeletal dysplasia.
They also suggested that a case of SMD described by Schmidt
et al,3 in 1963, represented the same entity. Finally, Matsu-
bayashi et al4 reported a Japanese boy with a heterozygous
missense mutation in COL2A1 gene, with the SMD-A pheno-
type and clarified that SMD-A is a variant within the type-II
collagenopathies.5
Here, we reported the clinical and radiological findings of
a new sporadic case of SMD-A in a 5-year-old boy with two
variants in the COL2A1 gene.
Clinical Manifestation
The patient was a Venezuelan boy referred to the Medical
Genetic Unit because of short stature and bone deformity at
5 years of age. He was born to healthy nonconsanguineous
parents. The family history was negative. Maternal urinary
tract infection was the only prenatal disturbance. The boy
was delivered vaginally at 386/7 weeks of gestation. His birth








Abstract Spondylometaphyseal dysplasia Algerian type (MIM no.: 184253) is an uncommon
autosomal dominant skeletal dysplasia caused by heterozygous mutations in the
COL2A1 gene (MIM no.: 120140). In this case based review, we reported a 5-year-old
boy with short stature, severe dorsolumbar scoliosis, lumbar hyperlordosis, short
trunk, and severe genu valgum. Radiological examination showed platyspondyly,
irregular metaphyseal radiolucencies intermingled with radiodensities, and corner
fractures. The patient has a c.3275G>A; p.Gly1092Asp mutation in exon 47 of the
COL2A1 gene and a variant of unknown significance in c.1366–13C> A in intron 21. This
latter sequence variant could partially or completely disrupt the natural splice acceptor
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weight was 4.5 kg (3.6 SD). He had a unilateral inguinoscrotal
hernia which was surgically corrected at 9 months of age.
Recurrent pneumonia was frequent and required another
hospitalization.
Except for late walking at the age of 30 months, his
psychomotor development was normal. Cardiovascular eval-
uation showed a small atrial septal defect that was closed
spontaneously. His abdominal and renal ultrasound studies
were normal.
When he was assessed at the age of 5 years of age, his
height was 70 cm (10.8 SD) and weight was 12.7 kg (2.6
SD). His facial featureswere unremarkable, except for a broad
forehead. Short neck and trunk with severe dorsolumbar
scoliosis and lumbar hyperlordosis were also evident. His
femora were kept in flexion and there was a wind-swept
deformity of the knees. He was also noted to have brachy-
dactyly and camptodactyly. His cognitive development was
within the normal range, and his ophthalmologic and audi-
ological examinations were normal. Routine blood and uri-
nary studies disclosed a phosphate level of 7.30mg/dL
(normal range: 3.4–6.8mg/dL).
Diagnosis
Radiological examination showed a normal skull, platyspon-
dyly, dorsolumbar scoliosis, and lumbar hyperlordosis. The
ilia were broad and short in their vertical dimension. The
proximal femoral epiphyses were in severe varus position
and mottled in appearance. His right knee was in valgus
position, the left mildly bowed. The metaphyseal margins of
the long bones were irregular with intermingled radiolucen-
cies and radiodensities (►Fig. 1). Corner fractures were
noted and the short tubular bones were minimally affected.
Blood samples from the patient were obtained with
informed consent from his mother, and genomic DNA was
extracted using standard methods.6 Coding exons and their
intron-exon boundaries were amplified by polymerase chain
reaction and sequenced to screen for COL2A1 mutations.
We identified two variants, one clearly pathogenic
and second potentially pathogenic in COL2A1 gene, c.3275G
>A; p.G1092D in exon 47 and c.1366–13C>A in intron 21.
Discussion
SMD-A is characterized by short-trunk dwarfism, scoliosis,
kyphosis, and severe leg deformities, all of which worsen
with age.1,3,4 Myopia is observed but was not found in our
patient. Radiologically, kyphoscoliosis, moderate platyspon-
dyly, and metaphyseal anomalies are prominent. Epiphyseal
ossification is retarded and mildly irregular, most conspicu-
ously in the capital femora epiphyses that may be irregularly
structured and in severe varus position.1,4
SMD-A belongs to the subgroup of type-II collagenopa-
thies with marked metaphyseal involvement which also
include Strudwick’s type, dysspondyloenchondromatosis,
and some cases of SMD corner fracture type.7 Its distinction
as a separate entity can be challenged but may be justified by
the severe involvement of the knee joints. COL2-related
SMDs must be differentiated from other SMD, notably
SMD corner-fracture type, Kozlowski’s SMD, axial SMD
with cone-rod dystrophy, and odontochondrodysplasia.8
Sequencing analysis of COL2A1 gene identified that our
patient carries two variants, one clearly pathogenic and
the second potentially pathogenic. The first one, c.3275G>A,
is a transition mutation involving a change of a guanine by an
adenine at codon 1092 in exon 47, leading to a missense
mutation in the proteinp.G1092D (rs794727684). This variant
was not fully described previously, although it was annotated
in theClinVardatabase (https://www.ncbi.nlm.nih.gov/clinvar/)
as likely pathogenic for Stickler’s syndrome type 1
(RCV000322756.1) andspondyloepiphyseal dysplasia congen-
ital (RCV000178624.1). To determine the pathogenicity of p.
G1092D, web-based packages were as follows: SIFT (v4.0.3)
classified themutation as deleterious (score: 0,median: 4.32);
and PolyPhen-2 considered this mutation as probably damag-
ingwith a score of 0.999 (sensitivity 0.14; specificity 0.99) and
that glycine in 1092 position is fully conserved in different
species.9 The Provean web server which calculates the func-
tional effect of missense and indels mutations predicted a
deleterious effect for p.G1092D with a score of 6.488 (cut-
off¼2.5); and Mutation Taster program (v2013) classified
this variation as a disease-causing mutation (p¼1).10,11
The second variant, c.1366–13C>A, is a base substitu-
tion located in intron 21 at 13 bp downstream from accep-
tor site splicing. This variant is annotated in ClinVar as of
uncertain significance associated with collagenopathies
type II (RCV000364110.1) and Stickler’s syndrome
(RCV000269517.1). It is a known dbSNP (144):
rs200984998 (MAF/MinorAlleleCount: T¼0.002/0) and
reported by Exome Variant Server (http://evs.gs.washing-
ton.edu; ID number: ESP6500SIV2) in European American
population with a frequency of 0.07% but not in African
American population. According to the ExAC Browser Beta
(http://exac.broadinstitute.org/), this variant was found in
different populations: American, 0.043%; European non-
Finnish, 0.093%; Finnish, 0.15%; and other populations,
0.11%. Mutation taster classified this change as a polymor-
phismwith 0.17 and 0.001 scores in PhyloP and PhastCons,
respectively. Moreover, this variant was reported in 1000
Genomes Project Phase 3 and was identified in
Fig. 1 (A) Radiological examination showed a dorsolumbar scoliosis.
(B) The ilia were broad and short in their vertical dimension. The
proximal femoral epiphyses were in severe varus position and mottled
in appearance. (C) The right knee was in valgus position, the left mildly
bowed. The metaphyseal margins of the long bones were irregular
with intermingled radiolucencies and radiodensities.
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heterozygous state in the Colombian population (with a
0.011 genotype frequency).12 It should be noted that the
paternal grandparents of the patient are from Colombia.
Furthermore, this change was analyzed using the Human
Splicing Finder predicting no significant splicing motif
alteration.13 However, c.1366C>A is suspected to be path-
ogenic because of predicted effect on the natural splice
acceptor site of intron 21/exon 22 using the splicing tool of
the Alamut Visual software (Interactive Biosoftware—a
Sophia Genetics Company, Rouen, France). The phenotypic
effect of c.1366C>A cannot be fully determined. An at-
tempt was made to study both parents, but they were not
available by the time the results from the study were
obtained. The c.1366–13C>Amutation, may be a potential
modifier of the patient’s phenotype, explaining the severe
clinical manifestation or just be a polymorphism inherited
from a healthy parent.
The most common mutations in COL2A1 occur in the
triple-helical domain. A mature type-II collagen is a homo-
trimeric protein, each chain is composed of 1,014 amino
acids with a glycine in every third position which is a key
amino acid to the helix folding and stability.14,15 The p.
G1092D mutation identified in our patient is located in
this domain and affects a glycine. Two main molecular
mechanisms are described in collagenopathies type 2. Dom-
inant-negative mutations, involving the substitution of gly-
cine in the triple helix, which dramatically impair mature
type-II collagen assembly and stability. An additional mech-
anism is haploinsufficiency, produced by nonsense muta-
tions or out-of-frame deletions, leading to a premature
termination codon; consequently, these mutations lead to
a reduction in protein synthesis.5
Two different mutations in a patient with an autosomal
dominant disease such as collagenopathies type 2 is not
common. This phenomenon displays two possible scenari-
os. Thefirst one is that the intronicmutation could be acting
like a genetic modifier, resulting in a more severe pheno-
type in this patient. The second scenario is that the muta-
tions are not in cis but trans, and so the mutations were
inherited in an autosomal recessive fashion. However, in
other type-II collagenopathies, a double heterozygous mu-
tation was previously reported in a Japanese patient with
spondyloepiphyseal dysplasia congenital phenotype. In this
case, both mutations were located in the coding sequence
for the triple helix domain and a severe phenotypewas also
reported.16
An additional mutation was described in another Japa-
nese patient with SMD-A phenotype who presented with
short stature, severe leg deformity, severe genu valgum,
myopia, and hearing impairment. This patient had a hetero-
zygous missense mutation located in the triple helical do-
main (p.G861V) in COL2A1. Regarding skeletal alterations,
our patient showed a more severe phenotype than the
previously reported patient. However, neither myopia nor
deafness was described in our patient.4
Conclusion
This study reports the clinical and radiological findings of a
new case of SMD-A presenting new COL2A1 genetic variants
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